Jynneos
Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen · Injection, Suspension · Subcutaneous
No FDA structured label text is available for Jynneos. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
Jynneos NDC products (5)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 50632-001 | Vaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen 50000000 1/.5mL Injection, Suspension | Bavarian Nordic A/S | BLA |
| 50632-002 | Vaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen 50000000 1/.5mL Injection, Powder, Lyophilized, For Suspension | Bavarian Nordic A/S | BLA |
| 50632-022 | Vaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen 50000000 1/.5mL Injection, Suspension | Bavarian Nordic A/S | BLA |
| 50632-023 | Vaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen 50000000 1/.5mL Injection, Suspension | Bavarian Nordic A/S | BLA |
| 50632-024 | Vaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen 50000000 1/.5mL Injection, Powder, Lyophilized, For Suspension | Bavarian Nordic A/S | BLA |
Frequently asked questions
Who makes Jynneos?
Jynneos is listed by 1 labeler in the FDA NDC directory, including Bavarian Nordic A/S.